REGN - Regeneron Pharmaceuticals, Inc

Healthcare - Sector
Coverage Profile Rating Distribution Performance Price Targets & Ratings Chart

REGN is currently covered by 32 analysts with average potential upside of $59.6 (12.73%) backed by 557 price targets and 607 ratings. Documented since 27-Feb-2009. Analyst's average stock valuation to be materialised ratio is 87.33% with an average time for price targets to be met of 239.38 days.

Most recent stock forecast was given by BRIAN SKORNEY from BAIRD on 24-Mar-2023.

Highest price target for REGN is 820, Lowest price target is 497, average price target is 658.5.

Intuitive Surgical, Inc. is a healthcare company that specializes in the development, manufacture, and marketing of products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company’s flagship product is the da Vinci Surgical System, which allows for complex surgeries to be performed using a minimally invasive approach.

The da Vinci Surgical System is a robotic surgical system that includes a console where the surgeon sits and controls the instruments, as well as a patient-side cart that holds the instruments and a high-definition 3D camera. The surgeon uses the console to control the instruments, which are inserted into the patient’s body through small incisions. The system allows for greater precision and control during surgery, resulting in reduced trauma to the patient and faster recovery times.

In addition to the da Vinci Surgical System, Intuitive Surgical offers the Ion endoluminal system, which extends the company’s commercial offerings beyond surgery into diagnostic procedures. The Ion system enables minimally invasive biopsies in the lung, which can help diagnose lung cancer and other conditions.

Intuitive Surgical also provides a suite of stapling, energy, and core instrumentation for its surgical systems, as well as progressive learning pathways to support the use of its technology. The company offers a complement of services to its customers, including support, installation, repair, and maintenance, to ensure that its products operate efficiently and effectively.

Moreover, Intuitive Surgical has integrated digital capabilities providing connected offerings that streamline performance for hospitals with program-enhancing insights. The company was founded in 1995 and is headquartered in Sunnyvale, California. Since its founding, the company has been at the forefront of developing and promoting minimally invasive surgical techniques, and it has revolutionized the field of surgery by introducing robotic technology that has made surgeries safer, less invasive, and more efficient.

Currently, out of the existing stock ratings of REGN - 52 which are a Hold (31.71%), 105 which are a Buy (64.02%), 7 which are a Sell (4.27%)

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score



$-20 (-2.44%)


3 days ago

20/22 (90.91%)

$14.75 (5.01%)




$220 (26.83%)


3 days ago

21/22 (95.45%)

$114.4 (20.61%)




$95 (11.59%)


3 days ago

9/11 (81.82%)

$86.48 (15.43%)



3 days ago

4/4 (100%)

$85.18 (22.56%)




$95 (11.59%)


3 days ago

13/14 (92.86%)

$69.73 (13.98%)


Show more analysts

What is REGN(Regeneron Pharmaceuticals, Inc) average time for price targets to be met?

On average it took 239.38 days on average for the stock forecasts to be realized with a an average price target met ratio 87.33

Which analyst has the current highest performing score on REGN(Regeneron Pharmaceuticals, Inc) with a proven track record?